1. Home
  2. RGP vs ESPR Comparison

RGP vs ESPR Comparison

Compare RGP & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGP
  • ESPR
  • Stock Information
  • Founded
  • RGP 1996
  • ESPR 2008
  • Country
  • RGP United States
  • ESPR United States
  • Employees
  • RGP N/A
  • ESPR N/A
  • Industry
  • RGP Business Services
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGP Consumer Discretionary
  • ESPR Health Care
  • Exchange
  • RGP Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • RGP 178.9M
  • ESPR 208.1M
  • IPO Year
  • RGP 2006
  • ESPR 2013
  • Fundamental
  • Price
  • RGP $5.14
  • ESPR $1.22
  • Analyst Decision
  • RGP Sell
  • ESPR Buy
  • Analyst Count
  • RGP 1
  • ESPR 7
  • Target Price
  • RGP $5.00
  • ESPR $5.93
  • AVG Volume (30 Days)
  • RGP 183.3K
  • ESPR 6.1M
  • Earning Date
  • RGP 07-17-2025
  • ESPR 05-06-2025
  • Dividend Yield
  • RGP 9.52%
  • ESPR N/A
  • EPS Growth
  • RGP N/A
  • ESPR N/A
  • EPS
  • RGP N/A
  • ESPR N/A
  • Revenue
  • RGP $560,189,000.00
  • ESPR $259,574,000.00
  • Revenue This Year
  • RGP N/A
  • ESPR $4.07
  • Revenue Next Year
  • RGP $3.85
  • ESPR N/A
  • P/E Ratio
  • RGP N/A
  • ESPR N/A
  • Revenue Growth
  • RGP N/A
  • ESPR 12.99
  • 52 Week Low
  • RGP $4.81
  • ESPR $0.69
  • 52 Week High
  • RGP $12.19
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • RGP 43.36
  • ESPR 69.05
  • Support Level
  • RGP $5.05
  • ESPR $0.81
  • Resistance Level
  • RGP $5.34
  • ESPR $0.88
  • Average True Range (ATR)
  • RGP 0.19
  • ESPR 0.08
  • MACD
  • RGP 0.01
  • ESPR 0.06
  • Stochastic Oscillator
  • RGP 46.15
  • ESPR 90.20

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: